NutriSystem (NTRI) Rating Increased to Outperform at Barrington Research

Barrington Research upgraded shares of NutriSystem (NASDAQ:NTRI) from a market perform rating to an outperform rating in a report published on Thursday morning, MarketBeat Ratings reports. Barrington Research currently has $44.00 price target on the stock.

“We are upgrading our investment rating to OUTPERFORM with a price target of $44, which assumes a conservative 10x EV/adjusted EBITDA multiple and a 16.5x P/E multiple.”,” the firm’s analyst commented.

Other equities analysts have also recently issued reports about the stock. DA Davidson raised shares of NutriSystem from an underperform rating to a neutral rating and raised their target price for the company from $28.00 to $36.00 in a research note on Thursday. ValuEngine cut shares of NutriSystem from a sell rating to a strong sell rating in a research note on Friday, August 24th. B. Riley raised their target price on shares of NutriSystem from $52.00 to $53.00 and gave the company a buy rating in a research note on Tuesday, July 31st. Zacks Investment Research raised shares of NutriSystem from a hold rating to a buy rating and set a $45.00 target price for the company in a research note on Thursday, August 2nd. Finally, BidaskClub cut shares of NutriSystem from a hold rating to a sell rating in a research note on Saturday, August 18th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $45.57.

Shares of NTRI traded down $1.16 during mid-day trading on Thursday, hitting $37.57. 718,525 shares of the company’s stock were exchanged, compared to its average volume of 846,030. The stock has a market capitalization of $982.25 million, a P/E ratio of 19.17, a P/E/G ratio of 1.62 and a beta of 1.27. NutriSystem has a 52 week low of $26.06 and a 52 week high of $55.10.

NutriSystem (NASDAQ:NTRI) last issued its quarterly earnings results on Tuesday, October 30th. The company reported $0.54 earnings per share for the quarter, hitting the consensus estimate of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 44.33%. The company had revenue of $159.30 million during the quarter, compared to analysts’ expectations of $164.18 million. During the same period last year, the business earned $0.49 EPS. The business’s quarterly revenue was up .8% on a year-over-year basis. Equities research analysts forecast that NutriSystem will post 2.1 EPS for the current year.

NutriSystem declared that its board has authorized a stock repurchase plan on Tuesday, October 30th that permits the company to repurchase $75.00 million in shares. This repurchase authorization permits the company to repurchase up to 7.7% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Monday, November 19th. Investors of record on Friday, November 9th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.00 annualized dividend and a dividend yield of 2.66%. NutriSystem’s dividend payout ratio is presently 51.02%.

Large investors have recently added to or reduced their stakes in the stock. Raymond James & Associates boosted its position in NutriSystem by 2.7% during the second quarter. Raymond James & Associates now owns 139,076 shares of the company’s stock worth $5,354,000 after purchasing an additional 3,620 shares during the period. Atria Investments LLC bought a new position in NutriSystem during the second quarter worth $394,000. First Mercantile Trust Co. bought a new position in NutriSystem during the second quarter worth $119,000. Point72 Asset Management L.P. bought a new position in NutriSystem during the second quarter worth $3,238,000. Finally, Aperio Group LLC bought a new position in NutriSystem during the second quarter worth $313,000.

About NutriSystem

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ‘D' kit that offers individuals with or at risk of type 2 diabetes.

See Also: Understanding each part of a balance sheet

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply